Potomac Capital Management’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$982K Hold
141,500
0.67% 37
2026
Q1
$582K Buy
141,500
+328
+0.2% +$1.59K 0.51% 41
2025
Q4
$939K Buy
+141,172
New +$956K 0.75% 35
2023
Q4
$1.63M Hold
154,847
1.9% 17
2023
Q3
$1.42M Hold
154,847
1.81% 17
2023
Q2
$1.13M Sell
154,847
-11,253
-7% -$97.1K 1.16% 24
2023
Q1
$1.41M Hold
166,100
1.47% 20
2022
Q4
$1.25M Buy
166,100
+100
+0.1% +$774 1.45% 16
2022
Q3
$1.34M Buy
166,000
+29,800
+22% +$316K 1.53% 17
2022
Q2
$1.58M Buy
136,200
+200
+0.1% +$2.36K 1.83% 17
2022
Q1
$1.53M Buy
136,000
+3,500
+3% +$29.8K 1.32% 20
2021
Q4
$863K Buy
+132,500
New +$909K 0.76% 35

Other funds holding EOLS

Potomac Capital Management's EOLS Position: Q2 2026 in Review

Potomac Capital Management held its Evolus (EOLS) position steady in Q2 2026 at 141,500 shares worth $982K. The position accounts for 0.67% of the portfolio, ranked #37.

Potomac Capital Management first reported a position in EOLS in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.63M in Q4 2023. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Potomac Capital Management held 141,500 shares of Evolus worth $982K as of Q2 2026.
  • Potomac Capital Management left its Evolus share count unchanged in Q2 2026.
  • Evolus made up 0.67% of Potomac Capital Management's portfolio in Q2 2026, its #37 holding.
  • Potomac Capital Management first reported a position in Evolus in Q4 2021 and has held it in 12 quarters since.
  • Potomac Capital Management's Evolus position peaked at $1.63M in Q4 2023.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Potomac Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.